Stay updated on Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.

Latest updates to the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page
- Check6 days agoChange DetectedAdded the MeSH term Malignant lymphoma, large B-cell, diffuse to the study indexing terms and included a Genetic and Rare Diseases Information Center resources entry.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check63 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check70 days agoChange DetectedMinor UI and policy text updates were made, including adding a 'Show glossary' option, adjusting the QC criteria label capitalization, and updating the 'No FEAR Act Data' and revision labels from v3.3.4 to v3.4.0. These changes do not affect the core trial content, eligibility, outcomes, or study details.SummaryDifference0.2%

Stay in the know with updates to Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.